Xarelto vs. Savaysa

See how Xarelto and Savaysa compare on approved uses, dosing, side effects, and cost.

Andre Stone | MD

Medically reviewed by Andre Stone | MD, University of Pittsburgh School of Medicine on September 8th, 2026.

Key Takeaways

  • Xarelto and Savaysa are oral factor Xa inhibitors that are generally taken once daily, although Xarelto starts with twice-daily dosing for the first three weeks of DVT or PE treatment.

  • Savaysa's dosing is simpler, with just two possible doses, while Xarelto requires a twice-daily start dose for the first three weeks when treating DVT or PE.

  • Savaysa should not be used for stroke prevention in atrial fibrillation when creatinine clearance is greater than 95 mL/min because it was less effective than warfarin in this group. A clinician calculates creatinine clearance before prescribing it.

Xarelto vs. Savaysa Drug Summary

Xarelto

Xarelto (rivaroxaban) is a factor Xa inhibitor that lowers the risk of stroke in atrial fibrillation and treats or prevents blood clots like DVT and PE. It's taken as an oral tablet, usually once daily, though some uses start with a twice-daily dose for three weeks.

Savaysa

Savaysa (edoxaban) is a factor Xa inhibitor used to lower stroke risk in atrial fibrillation and to treat DVT or PE. It's taken as a single oral tablet once a day, at either 60 mg or 30 mg depending on weight, kidney function, and other medications.

Xarelto vs. Savaysa Side Effects

Xarelto

Most common
major bleeding (3.6% per year)
rash (1% to 10%)
pruritus (1% to 10%)
back pain (common)

Savaysa

Most common
major bleeding (1% to 10%)
rash (4.2%)
anemia (9.6%)
abnormal LFTs (4.8%)

Xarelto vs. Savaysa Dosage

Xarelto

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily At the start
Maximum dose 20 mg once daily Day 22 onward
Dose changes 3 increases Every 21 days

Savaysa

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 60 mg once daily At the start
Maximum dose 30 mg once daily If needed
Dose changes 1 increase As tolerated

Xarelto vs. Savaysa Indications

Xarelto

Xarelto is FDA-approved for a wide range of clotting conditions, from atrial fibrillation-related stroke prevention to DVT and PE treatment and prevention. It's also approved for VTE prophylaxis after hip or knee replacement surgery and in acutely ill hospitalized patients.

  • Stroke prevention in nonvalvular atrial fibrillation

  • Treatment of DVT and PE

  • Reducing risk of DVT/PE recurrence

Savaysa

Savaysa is FDA-approved for stroke prevention in nonvalvular atrial fibrillation and for treating DVT or PE. It is not approved for VTE prevention after surgery, and it isn't recommended for AFib patients whose kidneys work very well, since it was less effective than warfarin in that group.

  • Stroke prevention in nonvalvular atrial fibrillation

  • Treatment of DVT

  • Treatment of PE

Xarelto vs. Savaysa Pros and Cons

Xarelto

Xarelto has the broadest set of FDA-approved uses among direct factor Xa inhibitors, covering AFib, VTE treatment, and surgical VTE prevention. It also has a specific reversal agent for bleeding emergencies, andexanet alfa, and has been on the market longer with an established safety record.

Pros

  • Approved for surgical VTE prophylaxis, unlike Savaysa

  • Reversal agent (andexanet alfa) available for bleeding

  • Oral suspension option for children or swallowing issues

Cons

  • Initial DVT/PE treatment requires twice-daily dosing for 3 weeks

  • Boxed warning for spinal or epidural hematoma with spinal procedures

  • More dosing steps to track during the titration period

Savaysa

Savaysa has two usual daily doses and does not use a dose-titration period. However, when it is used to treat DVT or PE, it is started only after 5 to 10 days of an injectable anticoagulant. It has fewer FDA-approved uses, though, and carries a boxed warning against use in atrial fibrillation patients with very good kidney function.

Pros

  • Simpler dosing: one tablet a day, no titration phase

  • Only two dose strengths to manage (60 mg or 30 mg)

  • No twice-daily start dose needed for DVT or PE treatment

Cons

  • Not approved for VTE prevention after hip or knee surgery

  • Boxed warning: less effective in AFib patients with excellent kidney function

  • Requires 5 to 10 days of injectable blood thinner first for DVT/PE

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.

Compare Xarelto and Savaysa

Chat Now